Literature DB >> 2479134

Lessons from magnetic resonance imaging in multiple sclerosis.

W I McDonald, D Barnes.   

Abstract

Magnetic resonance imaging is a potent diagnostic tool in multiple sclerosis: it can reveal dissemination of lesions in both space and time in many patients with isolated neurological syndromes. Many more new lesions occur than clinical relapses. A consistent very early event is the breakdown of the blood-brain barrier which is largely repaired over weeks, leading to marked changes in the size of acute lesions. Chronic lesions show persistent oedema and enlarge through cycles of renewed peripheral activity. The vascular changes reflect inflammation: the resulting MRI changes provide, for the first time, a non-invasive means of monitoring disease activity and its modification by treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2479134     DOI: 10.1016/0166-2236(89)90075-1

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  10 in total

1.  Limiting and repairing the damage in multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

2.  Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI.

Authors:  A Gass; I F Moseley; G J Barker; S Jones; D MacManus; W I McDonald; D H Miller
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

3.  Biochemical changes within a multiple sclerosis plaque in vivo.

Authors:  T A Cadoux-Hudson; A Kermode; B Rajagopalan; D Taylor; A J Thompson; I E Ormerod; W I McDonald; G K Radda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

4.  The pattern visual evoked potential. A multicenter study using standardized techniques.

Authors:  M Brigell; D I Kaufman; P Bobak; A Beydoun
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

5.  Micrographia associated with a parietal lobe lesion in multiple sclerosis.

Authors:  N J Scolding; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

6.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.

Authors:  Sheryl L Herrera; Vanessa L Palmer; Heather Whittaker; Blair Cardigan Smith; Annie Kim; Angela E Schellenberg; Jonathan D Thiessen; Richard Buist; Marc R Del Bigio; Melanie Martin
Journal:  Magn Reson Insights       Date:  2014-11-09

9.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

Authors:  K Kojima; T Berger; H Lassmann; D Hinze-Selch; Y Zhang; J Gehrmann; K Reske; H Wekerle; C Linington
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

Review 10.  Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

Authors:  G L Stoner
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.